NFKB1 and cancer: In a meta‐analysis updated to July 2016 involving 18,299 cases and 23,484 controls from 50 case‐control studies, Fu et al. y50 identified that the NFKB1 −94ins/delATTG polymorphism protects from getting overall cancer in the homozygote model; heterozygote model; dominant model; and allele contrast.